• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Livongo Appoints Boston Children’s Hospital CEO, Sandra L. Fenwick to Board of Directors

by Jasmine Pennic 05/14/2019 Leave a Comment

Livongo Appoints Boston Children's Hospital CEO, Sandra L. Fenwick to Board of Directors
Sandra L. Fenwick, CEO of Boston Children’s Hospital

Livongo, a Mountain View, CA-based Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it has appointed Sandra L. Fenwick, Chief Executive Officer of Boston Children’sHospital, to its Board of Directors.

Sandra L. Fenwick Bio & Background

Since being named Chief Executive Officer of Boston Children’s Hospital in 2013, Ms. Fenwick has led the nation’s foremost independent pediatric hospital and the world’s leading center of pediatric medical and health research.  She has been a driving force to improve the effectiveness and efficacy of the care provided at Boston Children’s, while at the same time reducing the cost of care. Ms. Fenwick joined Boston Children’s in 1999 as Senior Vice President and was appointed Chief Operating Officer that year. She was named President in 2008 and was appointed Chief Executive Officer in 2013. Boston Children’s is a Harvard teaching hospital with more than $2.6 billion of annual revenue including $385 million of research funding. Boston Children’s has 1,600 physicians, trains more than 1,000 residents and fellows annually, and has more than 12,000 employees.

Ms. Fenwick currently serves on the boards of directors of Harvard’s Wyss Institute for Biologically-inspired Engineering, Children’s Hospital Association, Greater Boston Chamber of Commerce, CRICO, Ltd., Massachusetts Digital Health Council, and Boston Children’s Hospital. She is also a member of the Massachusetts Women’s Forum and Women Corporate Directors/Boston. She holds a Bachelor’s degree from Simmons College with distinction and a Master’s in Public Health degree in Health Services Administration from the University of Texas School of Public Health. She has received numerous awards and honorary degrees for her contributions to healthcare.

Why It Matters

Sandi has been a true thought leader and champion for advancements in pediatric care and finding new ways to expand access to preventive care including asthma, obesity and mental health,” said Livongo Founder and Executive Chairman Glen Tullman. “By implementing an innovative business model, Sandi has built one of the highest quality-of-care settings in the country today. Livongo will leverage her deep experience and commitment as we continue to grow our Board of Directors.”

Tagged With: Applied Health Signals, Asthma, Boston Children's Hospital, digital health, Glen Tullman, Livongo, Mental Health, physicians, Public Health

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

ViVE 2023 Executive Takeaways

VIVE 2023: 6 Digital Health Executives Share Their Key Takeaways

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |